Answers are grounded in this paper and cite their sources.
PURPOSE: The aim of this study was to assess dynamic susceptibility contrast (DSC) perfusion-weighted magnetic resonance (MR) imaging and diffusion-weighted MR imaging in differentiating recurrent head and neck cancer from postradiation changes. METHODS: A prospective study was done on 41 patients with head and neck cancer after radiotherapy who underwent diffusion-weighted MR imaging, DSC perfusion-weighted MR imaging, and routine postcontrast MR imaging. The apparent diffusion coefficient (ADC) map and time signal intensity curve of the lesion were created. The ADC value, DSC percentage (DSC%), and contrast enhancement percentage of the lesion were calculated. The final diagnosis was done with biopsy. RESULTS: There was significant difference (P = 0.001) in ADC between recurrent cancer (0.94 ± 0.16 × 10mm/s) and postradiation changes (1.37 ± 0.12 × 10mm/s). There was significant difference (P = 0.001) in DSC% of recurrent cancer (30.9% ± 5.16%) and postradiation changes (12.1% ± 3.06%). Selection of ADC equal to or less than 1.07 × 10mm/s and DSC% greater than 16.6% to predict recurrence have areas under the curve of 0.822 and 0.900 and accuracy of 92.7% and 95.1%, respectively. Combination of ADC and DSC% has are under the curve of 0.992 and accuracy of 97.6%. CONCLUSIONS: Combined ADC and DSC% are noninvasive imaging parameters that can play a role in the differentiation of recurrent head and neck cancer from postradiation changes.
No takes yet. Share an insight, caveat, or question.
Razek et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: